Association between systemic lupus erythematosus and Helicobacter pylori seronegativity

Journal of Rheumatology

Volumn 31, Issue 8, 2004, Pages 1546-1550

  Sawalha, Amr H ^a   Schmid, Wendi R ^b   Binder, Steven R ^c   Bacino, Debra K ^b   Harley, John B ^a,b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c Life Science Group

Author keywords

Helicobacter pylori; Infection; Lupus; Serology

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOASSAY; IMMUNOREGULATION; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASLES; MUMPS; PEDIGREE; PRIORITY JOURNAL; RACE DIFFERENCE; RUBELLA; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; VARICELLA ZOSTER VIRUS;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; CHILD; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; SEX DISTRIBUTION;

EID: 3442889943     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hochberg MC. The epidemiology of systemic lupus erythematosus. In: Wallace DJ, Hahn B, editors. Dubois' lupus erythematosus. Baltimore: Williams & Wilkins; 1997:49-65.
2. James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJA. Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997;100:3019-26.
3. Harley JB, James JA. Epstein-Barr virus infection may be an environmental factor for systemic lupus erythematosus in children and teenagers [letter]. Arthritis Rheum 1999;42:1782-3.
4. James JA, Neas BR, Moser KL, et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis. Rheum 2001:44:1122-6.
5. James JA, Gross T, Scofield RH, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B' derived PPPGMRPP and PPPGIRGP induced spliceosome autoimmunity. J Exp Med 1995;181:453-61.
6. James JA, Scofield RH, Harley JB. Lupus humoral autoimmunity after short peptide immunization. Ann NY Acad Sci 1997;815:124-7.
7. Arbuckle MR, James JA, Kohlhase KF, Rubertone MV, Dennis GJ, Harley JB. Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand J Immunol 2001;54:211-9.
8. Logan RPH, Walker MM. Epidemiology and diagnosis of Helicobacter pylori infection. BMJ 2001;323:920-2.
9. Suerbaum S, Michetti P. Medical progress: Helicobacterpylori infection. N Engl J Med 2002;345:1175-86.
10. The EuroGast Study Group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993;34:1672-6.
11. Sitas F, Forman D, Yarnell JW, et al. Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut 1991;32:25-8.
12. Webb PM, Knight T, Greaves S, et al. Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. BMJ 1994; 308:750-3.
13. Marshall B. Helicobacter pylori: 20 years on. Clin Med 2002;2:147-52.
14. Kuipers EJ, Pena AS, van Kamp G, et al. Seroconversion for Helicobacter pylori. Lancet 1993;342:328-31.
15. Kosunen TU, Seppala K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-5.
16. Halme L, Rautelin H, Leidenius M, Kosunen TU. Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease, J Clin Pathol 1996;49:65-7.
17. Parente F, Molteni P, Bollani S, et al. Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases. A cross-sectional study with matching. Scand J Gastroenterol 1997;32:1140-6.
18. Pearce CB, Duncan HD, Timmis L, Green JR. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2000;12:439-43.
19. Vare PO, Heikius B, Silvennoinen JA, et al. Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor? Scand J Gastroenterol 2001;36:1295-300.
20. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
21. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
22. Karttunen TJ, Niemela S, Kerola T. Blood leukocyte differential in Helicobacter pylori infection. Dig Dis Sci 1996;41:1332-6.
23. Mendall M, Patel P, Ballam L, Strachan D, Northfield T. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996;312:1061-5.
24. Mendall MA, Patel P, Asante M. et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997;78:273-7.
25. Leontiadis GI, Sharma VK, Howden CW. Non-gastrointestinal tract associations of Helicobacter pylori infection. Arch Intern Med 1999;159:925-40.
26. Showji Y, Nozawa R, Sato K, Suzuki H. Seroprevalence of Helicobacter pylori in patients with connective tissue diseases. Microbiol Immunol 1996;40:499-503.
27. Thye T, Burchard GD, Nilius M, Muller-Myhsok B, Horstmann RD. Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection. Am J Hum Genet 2003;72:448-53.
28. EI-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
29. Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS. Helicobacter pylori-specific CD4+ CD25 high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 2003;71:1755-62.